Related Experiment Video
Updated: Jul 7, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Solid cerebral microemboli and cerebrovascular symptoms in patients with prosthetic heart valves
Mona Skjelland1, Annika Michelsen, Frank Brosstad
1Department of Neurology, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway. mona.skjelland@rikshospitalet.no
Insights
Solid cerebral microemboli detected via transcranial Doppler ultrasonography in mechanical heart valve patients correlate with cerebrovascular symptoms. This finding may help predict ischemic stroke risk in this population.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Medical Imaging
Background:
- Cerebral microemboli are frequently detected in patients with mechanical heart valves.
- The clinical significance of these microemboli remains unclear.
- Prosthetic heart valves, both mechanical and biologic, are used to treat valvular heart disease.
Purpose of the Study:
- To determine the frequency and composition of cerebral microemboli in prosthetic heart valve patients.
- To correlate microemboli findings with cerebrovascular symptoms.
- To investigate the relationship between microemboli, inflammation, and coagulation parameters.
Main Methods:
- Seventy-six patients with 81 prosthetic heart valves underwent multifrequency transcranial Doppler ultrasonography one year post-valve replacement.
- Cerebrovascular events were recorded by a neurologist.
- Inflammation and coagulation markers were measured using immunoassays.
Main Results:
- Microemboli were exclusively detected in mechanical heart valve patients (56%).
- Solid microemboli were identified in 34% of mechanical heart valve patients.
- The presence of solid microemboli was significantly associated with cerebrovascular symptoms (P=0.026) and elevated monocyte chemotactic protein-1 levels (P=0.014).
Conclusions:
- Solid cerebral microemboli are detectable in a significant portion of mechanical heart valve patients.
- The detection of solid microemboli is linked to cerebrovascular events.
- Detecting solid microemboli may aid in predicting ischemic stroke risk in mechanical heart valve recipients.
Background And Purpose:
Although cerebral microemboli are often detected by transcranial Doppler ultrasonography in mechanical heart valve patients, the clinical significance of such microemboli is unclear. The aim of this study was to determine the frequency and composition of cerebral microemboli in a prosthetic heart valve population and to correlate these findings to cerebrovascular symptoms, blood inflammation, and coagulation parameters.
Methods:
Seventy-six consecutive patients with a total of 81 prosthetic (54 mechanical, 27 biologic) heart valves were monitored for cerebral microemboli by multifrequency transcranial Doppler ultrasonography 1 year after valve replacement. Cerebrovascular events in the first year were recorded by a neurologist. Inflammation and coagulation markers were measured by immunoassays.
Results:
Microemboli were detected in mechanical heart valve patients only (28 patients, 56%). Twelve percent were solid, occurring in 17 (34%) of the mechanical heart valve population. The presence of solid cerebral microemboli was the only variable that was associated with cerebrovascular symptoms after a final regression analysis (P=0.026). The plasma monocyte chemotactic protein-1 level was raised in patients with solid microemboli (P=0.014).
Conclusions:
Solid cerebral microemboli were detected by multifrequency transcranial Doppler ultrasonography in 35% of a mechanical heart valve population, and the frequency was higher in patients who experienced cerebrovascular events during the first year after valve replacement. The results suggest that the detection of solid cerebral microemboli may be helpful in predicting the risk of ischemic stroke in mechanical heart valve patients.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Cerebral Edema ll: Pathophysiology
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
